Enovis (ENOV) Change in Accured Expenses (2010 - 2011)

Enovis' (ENOV) quarterly Change in Accured Expenses came in at -$9.4 million in Q4 2011, down 159.9% year-on-year from $15.7 million in Q4 2010, and down 1109.98% on a QoQ basis from $932000.0 in Q3 2011.

Enovis (ENOV) Change in Accured Expenses (2010 - 2011) Analysis & Trends

Enovis (ENOV) has 2 years of Change in Accured Expenses data on file, last reported at -$9.4 million in Q4 2011.

  • On a quarterly basis, Change in Accured Expenses fell 159.9% year-over-year to -$9.4 million in Q4 2011; TTM through Dec 2011 was $16.0 million, a N/A change from a year earlier, with the FY2011 full-year figure at -$10.9 million, down 150.1% from the prior year.
  • Change in Accured Expenses for Q4 2011 stood at -$9.4 million, down from $932000.0 in the prior quarter.
  • Over the last five years, Change in Accured Expenses for ENOV reached as high as $15.7 million in Q4 2010 and fell as low as -$9.4 million in Q4 2011.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Abbott Laboratories 183.48 Bn 176.19 Bn 6.27 Bn -
2 Stryker 129.11 Bn 126.23 Bn 3.81 Bn -654.00 Mn
3 Medtronic 108.35 Bn 99.13 Bn 6.41 Bn 123.00 Mn
4 Boston Scientific 68.68 Bn 67.22 Bn 3.61 Bn -512.00 Mn
5 Edwards Lifesciences 48.35 Bn 44.67 Bn 1.29 Bn -347.10 Mn
6 Dexcom 28.38 Bn 27.26 Bn 750.30 Mn 145.10 Mn
7 GE HealthCare Technologies 28.04 Bn 25.76 Bn 1.98 Bn -250.00 Mn
8 Smith & Nephew 26.92 Bn 26.35 Bn - -
9 Koninklijke Philips 24.06 Bn 20.93 Bn 2.07 Bn 21.07 Mn
10 Enovis 1.59 Bn 1.56 Bn 365.49 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2011 -9.41 Mn
Dec 31, 2011 -9.41 Mn
Sep 30, 2011 932,000.00
Sep 30, 2011 932,000.00
Dec 31, 2010 15.72 Mn
Dec 31, 2010 15.72 Mn
Oct 1, 2010 8.74 Mn
Oct 1, 2010 8.74 Mn